SECURITIES AND EXCHANGE COMMISSION
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of February 2003
FRESENIUS MEDICAL CARE CORPORATION
Else-Kröner Strasse 1
61346 Bad Homburg
Germany
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes [ ] No [X]
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82
SIGNATURES | ||||||||
Exhibit 99.1 (Press Release) |
EXHIBITS
Exhibit 99.1 | Press release dated February 25, 2003 |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
DATE: February 25, 2003
Fresenius Medical Care Aktiengesellschaft |
||||
By: | /s/ Dr. Ben Lipps | |||
Name: | Dr. Ben Lipps | |||
Title: | Chairman of the Management Board | |||
By: | /s/ Dr. Ulf M. Schneider | |||
Name: | Dr. Ulf M. Schneider | |||
Title: | Chief Financial Officer |
3